ArticleObesity science & practice2017

Real-world weight change among patients treated with glucagon-like peptide-1 receptor agonist, dipeptidyl peptidase-4 inhibitor and sulfonylureas for type 2 diabetes and the influence of medication adherence.

G S Carls et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.